Presbyopia

Johnson & Johnson announces investment in TECLens for refractive vision correction initiatives

Johnson & Johnson Innovation has invested in Series A funding for the start-up TECLens, which is developing a novel, nonincisional refractive correction procedure that uses a corneal cross-linking (CXL) technology. The “investment demonstrates the company commitment to early-stage innovation, refractive technologies, and ultimately addressing patient unmet needs in eye health,”...